BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
Letrozol (Femara), toote foto

Laboriaruanne

PDF
Testitud
Testitud
Letrozol (Femara) 2.5mg × 100 Tabs
Labor
Analiza Białek
Kuupäev
October 2026
Tulemus
2.72 mg per tablet (2.5 mg label)
Tellimuse nr
Parool

Sõltumatult testitud, kontrollitav parooliga otse laboris.

PCT & AI

Letrozol (Femara)

PCT & AI

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

Lühidalt

Letrozol (Femara) arvudes

Põhinäitajad meie leksikonist. Lohista punkti mööda kõverat, et näha, kui palju jääb pärast ühte annust arvutuslikult alles.

Täielik leksikoni artikkel

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~3 days

Half-life ~3 days
After 6 days: 25 %
Day 350 %Day 625 %Day 912.5 %Day 153.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 2 to 4 days, we calculate with the middle.

Half-life

about2-4days

Class
Aromatase inhibitornon-steroidal, reversible
Use
Oral1-2x per week
Sizes
2.5 mg2 sizes in the shop

Teadmised

Kõik teemal Letrozol (Femara)

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

Is letrozole approved?

Yes. In the USA letrozole has been approved as a prescription tablet since 25 July 1997 and ChEMBL lists phase 4 as the highest phase. The large studies concern breast cancer after menopause.

How much does letrozole lower estrogens?

In a study with 12 women who took both drugs one after the other, letrozole suppressed whole-body estrogen production by more than 99.1 percent and anastrozole by 97.3 percent. Estradiol in the blood fell by 87.8 percent with letrozole and estrone sulfate by 98.0 percent.

What did BIG 1-98 show?

Over 8,000 postmenopausal women with hormone-sensitive breast cancer received letrozole or tamoxifen. After five years an estimated 84.0 against 81.4 percent were free of recurrence and the risk of recurrence fell by 19 percent. In return skeletal and cardiac events as well as raised cholesterol were more common with letrozole.

What is known in PCOS?

In a study of 750 women with PCOS trying to conceive letrozole led to a live birth more often than clomiphene (27.5 against 19.1 percent) and to ovulation more often. Hot flushes were more common with clomiphene, fatigue and dizziness with letrozole.

What about bone and blood lipids?

Less estrogen means less protection for bone. In MA.17 5.8 percent on letrozole and 4.5 percent on placebo received a new osteoporosis diagnosis, the difference was not significant. In BIG 1-98 raised cholesterol was more common with letrozole.

How long does letrozole stay in the body?

The US label gives a terminal elimination half-life of about 2 days. According to the label a steady level is only reached after 2 to 6 weeks of daily use.

Võrdlused

Kuidas see võrdub

Seotud

Seotud tooted